VGXI Blog & News
Welcome to the VGXI blog where we examine scientific trends, innovation, technological advancements in plasmid DNA manufacturing, and uncover how next-generation therapeutics are shaping the future of medicine and improving patients’ lives.
VGXI accepted as a Member of the Biopharmaceutical Manufacturing Preparedness (BioMap) Consortium
VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines, is honored to announce its acceptance into the Biopharmaceutical Manufacturing Preparedness (BioMap) Consortium. The[…]
Read More
VGXI, accepted as a Member of the US Government’s Rapid Response Partnership Vehicle (RRPV)
VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid[…]
Read More
Future Proof Your Advanced Therapies Supply Chain with VGXI’s US-Based Plasmid CDMO Expertise
In the current landscape of biopharmaceutical drug development, finding a reliable and[…]
Read More
VGXI Inc. announces a strategic partnership with Sutro Biopharma Inc. to support growing clinical pipeline
VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid[…]
Read More
VGXI’s Expanded Manufacturing Capacity Addresses Plasmid DNA Supply Chain Challenges
Plasmid DNA (pDNA) is an essential part of the supply chain for advanced therapies and[…]
Read More
Five Qualities to Look for in a CDMO
As the biopharmaceutical industry increasingly turns to outsourcing, the key to success lies in[…]
Read More
Stephanie Burke Named as VGXI’s New Chief Accounting Officer
Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Stephanie Burke as its new[…]
Read More
VGXI’s Full Spectrum Plasmid DNA Solutions: From Discovery to Commercialization
Plasmids are small, circular, double-stranded DNA molecules that have become indispensable[…]
Read More
VGXI, Inc. Names Jeff Whitmore as New Chief Commercial Officer
Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Jeff Whitmore as its new Chief[…]
Read More
VGXI Celebrates the Grand Opening for its New Headquarters and Manufacturing Facility
With original operations based in The Woodlands, TX, industry recognized plasmid DNA contract[…]
Read More
